Conditionally replicative adenovirus-based mda-7/IL-24 expression enhances sensitivity of colon cancer cells to 5-fluorouracil and doxorubicin
Journal of Gastroenterology, 08/01/2012
Xu J et al. – The authors here provide evidence supporting conditionally replicative adenoviral vector–based gene therapy as a powerful strategy to enhance Melanoma differentiation associated gene–7/interleukin–24 (mda–7/IL–24)–dependent Multiple drug resistance (MDR) reversion of colon cancer cells.



